The Medical Device Master File (MFs) registration system is a key initiative. It provides an excellent pathway for global suppliers of raw materials, critical components, software, and manufacturing processes to protect their intellectual property and efficiently support their Chinese clients in completing product registration.

The medical device technical team of CIRS Group was invited to attend the event, and jointly held a special seminar on FDA & CE MDR Certification and NMPA Clinical Evaluation with the organizer. Empowering Chinese, Korean and global medical device enterprises to comply with regulations and expand overseas with professional regulatory services, CIRS Group has gained high attention and wide recognition from the industry.

중국NMPA 수입의료기기 등록

On March 22, 2026, Delegation from the French laboratory Helioscience and the German raw material supplier Uviva visited CIRS Testing. David Wan, Head of Strategic Development at CIRS Group and Managing Director of CIRS Europe, alongside the CIRS Testing team, warmly welcomed the visitors. The gathering facilitated dynamic discussions regarding emerging industry trends and opportunities for expanded collaboration within the testing sector.

Cut through the noise with this week’s essential regulatory headlines. We’ve distilled the most relevant updates across chemicals, food, and cosmetics so you can focus on action, not searching.

Cut through the noise with this week’s essential regulatory headlines. We’ve distilled the most relevant updates across chemicals, food, and cosmetics so you can focus on action, not searching.

Cut through the noise with this week’s essential regulatory headlines. We’ve distilled the most relevant updates across chemicals, food, and cosmetics so you can focus on action, not searching.

Our LinkedIn page has officially reached 5,000+ followers, and we want to take a moment to say thank you.

Recently, the Environmental Product Declaration (EPD) Promotion Centre formally announced the list of 11 Life Cycle Assessment (LCA) consulting service providers. CIRS Group secured one spot due to its accumulated technical expertise and professional capabilities in dual-carbon services. This marks the recognition of CIRS Group LCA consulting capabilities, thus enabling it to continue delivering more compliant and internationally compatible technical support for corporate green transitions.

On October 16, 2025, the Shanghai Municipal Medical Products Administration, Shanghai Municipal Health Commission, and Shanghai Customs jointly issued the Shanghai Pilot Work Plan for Service Guidance on Temporary Import of Clinically Urgent Drugs and Medical Devices. 《上海市关于临床急需药械临时进口服务指导工作方案（试行）》This new plan aims to streamline the temporary import process for clinically urgent drugs and medical devices in Shanghai, helping patients gain faster access to innovative medical products.